The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII) .

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals : Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.





We are looking for a POSTDOCTORAL RESEARCH to be part of the Graupera lab.

RESEARCH DESCRIPTION

Our research is devoted to study the biology of the endothelium and its role in disease towards the development of therapeutic strategies to target this compartment. Specifically, we aim to untackel the fundamental insights of vessel growth and function in developmental setting as well as to identify the pathological contexts in which the vasculature plays a critical role either intrinsically, as in vascular anomalies, or extrinsically as in cancer.

MAIN RESPONSABILITIES

- Experimental design of the project.

- Working with complex genetically engineered mouse models including monitoring of the colony.

- Isolation and culture of primary endothelial cells.

- Work with mouse models of vascular malformations.

- scRNAseq data, processing and analysing.

- Spatial scRNAseq data, processing and analysing.

- Supervision of master and PhD students.

- Write fellowships applications and manuscripts together with the PI.

- Prepare formal reports for oral and written presentations.

- Data integration and interpretation.

WHAT WE NEED

- PhD in the biomedicine or similar.

- Background in disease models.

- Expertise in vascular biology.

- Expertise in scRNAseq.





- A high level of motivation and interest.

- Ability to handle varying workloads and aptitude for teamwork.

- High level of collaborative and communicative skills.

- Good level of English speaking and writing skills (required). Spanish (helpful).

WHAT WE OFFER

- Temporary position: 3 years (postdoctoral contract).

- This position is funded by ‘la Caixa’ Foundation under the project code HR26-00476.

- An exciting and innovative research project.

- Working in the mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.

- Incorporation in a multinational and highly collaborative team.

- The stimulating environment of the Barcelona metropolitan area.

DEADLINE

Please submit your application by the end of 20th of Nov 2026

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence

📌 VAC_92_2026_POSTDOCTORAL RESEARCHER (España)
🏢 Institut de Recerca contra la Leucèmia Josep Carreras
📍 España